Donald P. McDonnell
Affiliations: | Duke University, Durham, NC |
Area:
Pharmacology, Biochemistry, Molecular BiologyWebsite:
https://scholars.duke.edu/person/donald.mcdonnellGoogle:
"Donald McDonnell"Bio:
https://www.ucc.ie/en/cancerbiology/education/people/progmanagement/exadvisoryboard/donaldmcdonnell/
https://scholar.google.com/citations?user=45eqt94AAAAJ&hl=en
Mean distance: (not calculated yet)
Parents
Sign in to add mentorBert W. O'Malley | grad student | 1987 | Baylor College of Medicine | |
(Analysis of the molecular structure of the vitamin D3 receptor.) |
Children
Sign in to add traineeCaroline E. Connor | grad student | 2000 | Duke |
Julianne M. Hall | grad student | 2000 | Duke |
Maria R. Hamilton | grad student | 2000 | Duke |
Ashini L. Wijayaratne | grad student | 2000 | Duke |
Erin A. Kimbrel | grad student | 2002 | Duke |
Nora K. McGhee | grad student | 2006 | Duke |
Linda Grasfeder | grad student | 2007 | Duke |
Tianyu Li | grad student | 2007 | Duke |
Niharika B. Mettu | grad student | 2007 | Duke |
Andrea Sherk | grad student | 2007 | Duke |
Carolyn D. DuSell | grad student | 2009 | Duke |
Hilary E. Wade | grad student | 2009 | Duke |
Sonja N. Brun | grad student | 2014 | Duke |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Li Z, Chen F, Chen L, et al. (2024) EstroGene2.0: A multi-omic database of response to estrogens, ER-modulators, and resistance to endocrine therapies in breast cancer. Biorxiv : the Preprint Server For Biology |
Artham S, Chang CY, McDonnell DP. (2022) Eosinophilia in cancer and its regulation by sex hormones. Trends in Endocrinology and Metabolism: Tem. 34: 5-20 |
Tsuji J, Li T, Grinshpun A, et al. (2022) Clinical Efficacy and Whole Exome Sequencing of Liquid Biopsies in a Phase IB/II study of Bazedoxifene and Palbociclib in Hormone Receptor-Positive Breast Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
Sammeta VR, Norris JD, Artham S, et al. (2022) A New Chemotype of Chemically Tractable Nonsteroidal Estrogens Based on a Thieno[2,3-]pyrimidine Core. Acs Medicinal Chemistry Letters. 13: 1151-1158 |
Chakraborty B, Byemerwa J, Krebs T, et al. (2022) Estrogen receptor signaling in the immune system. Endocrine Reviews |
Haines CN, Wardell SE, McDonnell DP. (2021) Current and emerging estrogen receptor-targeted therapies for the treatment of breast cancer. Essays in Biochemistry |
Andreano KJ, Baker JG, Park S, et al. (2020) The dysregulated pharmacology of clinically relevant ESR1 mutants is normalized by ligand-activated WT receptor. Molecular Cancer Therapeutics |
Chakraborty B, Bymerwa J, Baldi R, et al. (2020) Abstract A44: Pharmacologic targeting of estrogen receptor in melanoma to enhance antitumor immunity Cancer Immunology Research. 8 |
Cocce KJ, Jasper JS, Desautels TK, et al. (2019) The Lineage Determining Factor GRHL2 Collaborates with FOXA1 to Establish a Targetable Pathway in Endocrine Therapy-Resistant Breast Cancer. Cell Reports. 29: 889-903.e10 |
Wardell SE, Yllanes AP, Chao CA, et al. (2019) Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacy. Breast Cancer Research and Treatment |